Laboratory Nexus is pleased to present this fully built-out molecular diagnostics laboratory located in Louisiana. This opportunity represents an exceptional chance for an existing laboratory operator, healthcare organization, diagnostics company, or investor seeking an operational laboratory platform without the time and expense of a ground-up build.
The laboratory features a modern molecular workflow with established laboratory infrastructure, quality systemsg, and specialized equipment. It currently maintains an active CLIA certificate and successfully passed its most recent inspection in July 2026.
The facility includes multiple Thermo Fisher QuantStudio 5 systems, automated extraction instrumentation, ANDiS molecular analyzers, refrigerated centrifuges, ultra-low freezers, PCR workstations, laboratory refrigeration, pipetting systems, and other supporting laboratory equipment. The laboratory also utilizes the Diagnose laboratory information system (LIS).
Highlights
● Turnkey molecular diagnostics laboratory
● Louisiana
● Asking Price: $275,000
● Active CLIA laboratory
● Passed July 2026 inspection
● Established molecular workflow
● Modern equipment package included
● Ideal platform for molecular diagnostics, PCR testing, precision medicine, research support, or laboratory expansion
Facility Information
● Approximately 800 square feet
● Existing laboratory staff
● Existing business development infrastructure
● Laboratory space available for continued operations (subject to landlord approval, if applicable)
Included Assets
The sale is expected to include substantially all operational laboratory assets, including:
● Thermo Fisher QuantStudio 5 Systems
● Nextractor Automated Extraction Systems
● ANDiS 350 Instruments
● Laboratory refrigeration and ultra-low freezers
● Refrigerated centrifuges
● PCR workstation
● Electronic multichannel pipettes
● Laboratory furniture
● Laboratory benches and ancillary equipment
● Existing laboratory infrastructure
● Additional inventory to be transferred at closing
A detailed equipment and asset schedule will be provided to qualified buyers during due diligence.